Mnemosyne Pharmaceuticals
First-in-class subunit-selective NMDA receptor modulators to treat neuropsychiatric diseases, specifically schizophrenia and Alzheimer\'s.
Get a Demo and See the Full Profile
Get a demo today to see profiles of Mnemosyne Pharmaceuticals plus 5898 other startups.
